New study aims to make Weight-Loss drug easier to tolerate
Symptom relief
Not yet recruiting
This study tests whether a flexible, symptom-guided dosing plan for tirzepatide can reduce nausea and vomiting compared to the standard dosing plan in adults with obesity who do not have diabetes. Participants will be randomly assigned to one of two dosing strategies and followed…
Phase: NA • Sponsor: Dasman Diabetes Institute • Aim: Symptom relief
Last updated Jun 03, 2026 12:05 UTC